HIGHLIGHTS
- who: March and collaborators from the University of Catania, Italy have published the research work: Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study, in the Journal: (JOURNAL) of 31/Dec/2022
- what: The aim of the study was therefore to evaluate the propensity of Italian hematologists to attempt TFR in CML patients treated with low-dose TKIs, both at diagnosis and during follow-up.
SUMMARY
The aim of the study was therefore to evaluate the propensity of Italian . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.